Screening for diabetic retinopathy and reduced vision among Indigenous Australians in Top End primary care health services: a TEAMSnet sub-study.
diabetic retinopathy
primary health care
retinal imaging
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
25
05
2020
received:
13
01
2020
accepted:
21
06
2020
pubmed:
17
11
2020
medline:
15
12
2021
entrez:
16
11
2020
Statut:
ppublish
Résumé
Diabetic retinopathy (DR) prevalence is higher in Indigenous Australians than in other Australians and is a major cause of vision loss. Consequently, timely screening and treatment is paramount, and annual eye screening is recommended for Indigenous Australians. To assess the prevalence of DR, reduced vision and DR treatment coverage among Indigenous Australian adults with diabetes attending Top End indigenous primary care health services. A cross-sectional DR screening study conducted from November 2013 to December 2015 in two very remote Northern Territory Aboriginal primary healthcare services. In 287 subjects, the prevalence of non-proliferative DR, proliferative DR and clinically significant diabetic macular oedema was 37.3%, 5.4% and 9.0% respectively. Treatment coverage for PDR was 60% (of 10 patients) and for CSMO was 17% (of 23 patients). Vision data were available from 122 participants at one site. The proportion with normal vision, reduced vision, impaired vision and blindness was 31.1%, 52.5%, 15.6% and 0.8% respectively. Overall, ungradable monocular image sets (46%) were associated with poorer quality images and missing protocol images (both P < 0.001). Ungradable images for DR were associated with presence of small pupils/media opacities (P < 0.001). Ungradable images for diabetic macular oedema were associated with poorer image quality (P < 0.001), cataracts (P < 0.001) and small pupils (P = 0.04). A high prevalence of DR, CSMO and impaired vision was noted in Indigenous Australians with diabetes. Screening in primary care is feasible, but more effective screening methods are needed.
Sections du résumé
BACKGROUND
Diabetic retinopathy (DR) prevalence is higher in Indigenous Australians than in other Australians and is a major cause of vision loss. Consequently, timely screening and treatment is paramount, and annual eye screening is recommended for Indigenous Australians.
AIMS
To assess the prevalence of DR, reduced vision and DR treatment coverage among Indigenous Australian adults with diabetes attending Top End indigenous primary care health services.
METHODS
A cross-sectional DR screening study conducted from November 2013 to December 2015 in two very remote Northern Territory Aboriginal primary healthcare services.
RESULTS
In 287 subjects, the prevalence of non-proliferative DR, proliferative DR and clinically significant diabetic macular oedema was 37.3%, 5.4% and 9.0% respectively. Treatment coverage for PDR was 60% (of 10 patients) and for CSMO was 17% (of 23 patients). Vision data were available from 122 participants at one site. The proportion with normal vision, reduced vision, impaired vision and blindness was 31.1%, 52.5%, 15.6% and 0.8% respectively. Overall, ungradable monocular image sets (46%) were associated with poorer quality images and missing protocol images (both P < 0.001). Ungradable images for DR were associated with presence of small pupils/media opacities (P < 0.001). Ungradable images for diabetic macular oedema were associated with poorer image quality (P < 0.001), cataracts (P < 0.001) and small pupils (P = 0.04).
CONCLUSIONS
A high prevalence of DR, CSMO and impaired vision was noted in Indigenous Australians with diabetes. Screening in primary care is feasible, but more effective screening methods are needed.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1897-1905Informations de copyright
© 2020 Royal Australasian College of Physicians.
Références
Foreman J, Keel S, Xie J, Van Wijngaarden P, Taylor HR, Dirani M. Adherence to diabetic eye examination guidelines in Australia: the National Eye Health Survey. Med J Aust 2017; 206: 402-6.
Group DER. Frequency of evidence-based screening for retinopathy in type 1 diabetes. N Engl J Med 2017; 376: 1507-16.
Brazionis L, Jenkins A, Keech A, Ryan C, Brown A, Boffa J et al. Diabetic retinopathy in a remote indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project. Diabet Med 2018; 35: 630-9.
Brazionis L, Jenkins A, Keech A, Ryan C, Bursell S-E. An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian indigenous communities: protocol for the telehealth eye and associated medical services network (TEAMSnet) project, a pre-post study design. BMC Health Serv Res 2017; 17: 13.
Bourne RR, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health 2017; 5: e888-e97.
Horton MB, Silva PS, Cavallerano JD, Aiello LP. Clinical components of telemedicine programs for diabetic retinopathy. Curr Diab Rep 2016; 16: 129.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC et al. Guidelines on diabetic eye care: the International Council of Ophthalmology Recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 2018; 125: 1608-22.
Mitchell P, Foran S, Foran J. Guidelines for the Management of Diabetic Retinopathy. Canberra: National Health and Medical Research Council; 2008.
Xie J, Arnold AL, Keeffe J, Goujon N, Dunn RA, Fox S et al. Prevalence of self-reported diabetes and diabetic retinopathy in indigenous Australians: the National Indigenous Eye Health Survey. Clin Experiment Ophthalmol 2011; 39: 487-93.
Keel S, Xie J, Foreman J, Van Wijngaarden P, Taylor HR, Dirani M. The prevalence of diabetic retinopathy in Australian adults with self-reported diabetes: the National Eye Health Survey. Ophthalmology 2017; 124: 977-84.
O'Halloran RA, Turner AW. Evaluating the impact of optical coherence tomography in diabetic retinopathy screening for an Aboriginal population. Clin Experiment Ophthalmol 2018; 46: 116-21.
Moynihan V, Turner A. Coordination of diabetic retinopathy screening in the Kimberley region of Western Australia. Aust J Rural Health 2017; 25: 110-5.
Jaross N, Ryan P, Newland H. Prevalence of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 1. Clin Experiment Ophthalmol 2003; 31: 32-9.
Durkin SR, Casson R, Newland HS, Selva D. Prevalence of trachoma and diabetes-related eye disease among a cohort of adult Aboriginal patients screened over the period 1999-2004 in remote South Australia. Clin Experiment Ophthalmol 2006; 34: 329-34.
Diamond JP, McKinnon M, Barry C, Geary D, McAllister IL, House P et al. Non-mydriatic fundus photography: a viable alternative to fundoscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia? Aust N Z J Ophthalmol 1998; 26: 109-15.
Clark A, Morgan WH, Kain S, Farah H, Armstrong K, Preen D et al. Diabetic retinopathy and the major causes of vision loss in Aboriginals from remote Western Australia. Clin Experiment Ophthalmol 2010; 38: 475-82.
Landers J, Henderson T, Abhary S, Craig J. Prevalence and associations of diabetic retinopathy in indigenous Australians within Central Australia: the Central Australian ocular health study. Clin Experiment Ophthalmol 2010; 38: 393-7.
Murray RB, Metcalf SM, Lewis PM, Mein JK, McAllister IL. Sustaining remote-area programs: retinal camera use by Aboriginal health workers and nurses in a Kimberley partnership. Med J Aust 2005; 182: 520-3.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-64.
Keech AC, Mitchell P, Summanen P, O'Day J, Davis TM, Moffitt M et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370: 1687-97.
Xu D, Jenkins A, Ryan C, Keech A, Brown A, Boffa J et al. Health-related behaviours in a remote indigenous population with type 2 diabetes: a Central Australian primary care survey in the Telehealth Eye and Associated Medical Services Network (TEAMS net) project. Diabet Med 2019; 36: 1659-1670.
Virgili G, Menchini F, Casazza G, Hogg R, Das RR, Wang X et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev 2015; CD008081.
Taylor HR, Xie J, Fox S, Dunn RA, Arnold AL, Keeffe JE. The prevalence and causes of vision loss in indigenous Australians: the National Indigenous Eye Health Survey. Med J Aust 2010; 192: 312-8.
Schultz R, Quinn S, Wilson B, Abbott T, Cairney S. Structural modelling of wellbeing for indigenous Australians: importance of mental health. BMC Health Serv Res 2019; 19: 488.
Foreman J, Xie J, Keel S, Van Wijngaarden P, Taylor HR, Dirani M. The validity of self-report of eye diseases in participants with vision loss in the National Eye Health Survey. Sci Rep 2017; 7: 8757.